Budesonidum, Formoteroli fumaras dihydricus
| Medicinal product name | Bufomix Easyhaler 160 micrograms/4.5 micrograms inhalation, inhalation powder |
||||||
|---|---|---|---|---|---|---|---|
| Pharmaceutical form | Inhalation powder | ||||||
| Strength | 160 μg/4.5 μg inhalation | ||||||
| Information from the MAH on shortages | No information on expected shortages | ||||||
| Availability of medicinal product |
|
||||||
| Legal status | Prescription (Pr.) Next lowest cost medicine |
||||||
| Summary of product characteristics |  15-09-2020
|
||||||
| Package leaflet | 30-08-2022
|
||||||
| ATC code | R03AK07 – Drugs for obstructive airway diseases |
Medicinal products (7)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (160 µg/4,5 µg/dose) |
Inhaler | 14-0112-01 |
Labelling text Aug 30, 2022 |
|
|
Is available (according to the information provided by wholesalers) (174 containers) |
Tamro, Magnum Medical, Recipe Plus, Oribalt Rīga |
N120 (160 µg/4,5 µg/dose) |
Inhaler |
€ 33.45 * |
14-0112-02 |
Labelling text Aug 30, 2022 |
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N60 (160 µg/4,5 µg/dose) |
Inhaler and protective cover | 14-0112-03 |
Labelling text Aug 30, 2022 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N120 (160 µg/4,5 µg/dose) |
Inhaler and protective cover | 14-0112-04 |
Labelling text Aug 30, 2022 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N180: 3 × 60 (160 µg/4,5 µg/dose) |
Inhaler | 14-0112-05 |
Labelling text Aug 30, 2022 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N360: 3 × 120 (160 µg/4,5 µg/dose) |
Inhaler | 14-0112-06 |
Labelling text Aug 30, 2022 |
|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N240: 2 × 120 (160 µg/4,5 µg/dose) |
Inhaler | 14-0112-07 |
Labelling text Aug 30, 2022 |
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.
Registration information
| Marketing authorisation No. | 14-0112 |
|---|---|
| Date of authorisation | May 7, 2014 |
| Marketing authorisation holder, country | Orion Corporation, Finland |
